Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences
- PMID: 16736072
- PMCID: PMC1761923
- DOI: 10.15288/jsa.2006.67.529
Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences
Abstract
Objective: In this study, we sought to examine the prevalence, correlates, and consequences associated with simultaneous polydrug use and concurrent polydrug use of alcohol and prescription drugs. For purposes of this investigation, simultaneous polydrug use referred to the co-ingestion of different drugs at the same time, and concurrent polydrug use referred to the use of different drugs on separate occasions within the past 12 months.
Method: Undergraduate students attending a large public midwestern university in the United States were randomly selected to self-administer a Web survey. The sample consisted of 4,580 undergraduate students, with a mean (SD) age of 19.9 (2.0) years; the sample consisted of 50% women, and the racial breakdown was 65% white, 13% Asian, 7% black, 5% Hispanic, and 10% other race/ethnicity. The survey assessed simultaneous polydrug use and concurrent polydrug use of alcohol and four classes of prescription drugs: (1) pain medication, (2) stimulant medication, (3) sedative medication, and (4) sleeping medication.
Results: The 12-month prevalence for polydrug use involving alcohol and abusable prescription drugs was 12.1% (including 6.9% simultaneous polydrug use). The majority of polydrug use involving alcohol and each class of prescription drugs was simultaneous polydrug use, with the exception of sleeping medication. Simultaneous polydrug use was more prevalent among undergraduate students who were male, were white, and reported early initiation of alcohol use. Simultaneous polydrug use was associated with more alcohol-related and other drug use-related problems than concurrent polydrug use.
Conclusions: Based on the high prevalence and increased risk for consequences associated with simultaneous polydrug use of alcohol and prescription drugs, collegiate prevention efforts aimed at reducing substance abuse should clearly focus on co-ingestion of alcohol and prescription drugs.
Figures
References
-
- Bachman JG, O’Malley PM, Schullenberg JE, Johnston LD, Bryant AL, Merline AC. The Decline of Substance Using in Young Adulthood: Changes in Social Activities. Roles, and Beliefs. Mahwah, NJ: Lawrence Erlbaum; 2002.
-
- Bachman JG, Wadsworth KN, O’Malley PM, Johnston LD, Schulenberj JE. Smoking, Drinking, and Drug Use in Young Adulthood: The Impacts of New Freedoms and New Responsibilities. Mahwah, NJ: Lawrence Erlbaum; 1997.
-
- Barrett SP, Pihl RO. Oral methylphenidate-alcohol co-abuse. J Clin Psychopharmacol. 2002;22:633–634. - PubMed
-
- Cocco KM, Carey KB. Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients. Psychol Assess. 1998;10:408–414.
-
- Collins RL, Ellickson PL, Bell RM. Simultaneous polydrug use among teens: Prevalence and predictors. J Subst Abuse. 1998;10:233–253. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
